Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel)
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2019
Price : $35 *
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 04 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2018 Planned End Date changed from 1 Dec 2020 to 1 Mar 2022.
- 09 Feb 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Mar 2021.